Prognostic Factors for Survival of Stage IB Non-small Cell Lung Cancer Patients: A 10-Year Follow-Up Retrospective Study.

[1]  Haiquan Chen,et al.  Ten-year follow-up results of pure ground-glass opacity-featured lung adenocarcinomas after surgery. , 2023, The Annals of thoracic surgery.

[2]  Haiquan Chen,et al.  Subsolid lesions exceeding 3 centimeters: the ground-glass opacity component still matters. , 2021, The Annals of thoracic surgery.

[3]  Shuhang Wang,et al.  The Epidemiology of Ground Glass Opacity Lung Adenocarcinoma: A Network-Based Cumulative Meta-Analysis , 2020, Frontiers in Oncology.

[4]  Ahmedin Jemal,et al.  Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[5]  Yang Zhang,et al.  Distinct prognostic factors in patients with stage I non-small cell lung cancer with radiologic part solid or solid lesions. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  C. Powell,et al.  Global Epidemiology of Lung Cancer , 2019, Annals of global health.

[7]  Kenji Suzuki,et al.  Prognostic impact of a ground glass opacity component in the clinical T classification of non–small cell lung cancer , 2017, The Journal of thoracic and cardiovascular surgery.

[8]  B. Han,et al.  Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma , 2017, The Journal of thoracic and cardiovascular surgery.

[9]  Kenji Suzuki,et al.  Prognostic Impact of the Findings on Thin‐Section Computed Tomography in Patients with Subcentimeter Non–Small Cell Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  Heng Zhao,et al.  Visceral pleural invasion predict a poor survival among lung adenocarcinoma patients with tumor size ≤ 3cm , 2017, Oncotarget.

[11]  V. Rusch,et al.  Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[12]  Y. Takeshima,et al.  Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma. , 2016, The Annals of thoracic surgery.

[13]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  W. Liang,et al.  The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis. , 2015, Chest.

[15]  Gwénaël Le Teuff,et al.  Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  He Huang,et al.  Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer. , 2015, The Annals of thoracic surgery.

[17]  Masahiko Kusumoto,et al.  Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. , 2013, The Journal of thoracic and cardiovascular surgery.

[18]  Y. Nishiwaki,et al.  Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension. , 2010, Chest.

[19]  Y. Nishiwaki,et al.  Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. , 2005, The Journal of thoracic and cardiovascular surgery.

[20]  Y. Nishiwaki,et al.  Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment. , 2004, The Journal of thoracic and cardiovascular surgery.

[21]  A. Dujon,et al.  Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. , 2001, The Annals of thoracic surgery.

[22]  I Yoshino,et al.  Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage. , 1995, The Journal of thoracic and cardiovascular surgery.